MIRATAZ (MIRTAZAPINE) 5GM TRANSDERMAL OINTMENT VINV-MAR0-6005

MIRATAZ® (Mirtazapine Transdermal Ointment) 5g is a veterinary prescription appetite stimulant designed to manage unintended weight loss in cats, particularly those undergoing treatment for chronic illness, chemotherapy, or other conditions common in oncology settings. This FDA-approved transdermal formulation contains mirtazapine, an antidepressant that also acts as an antiemetic and appetite enhancer. Applied topically to the inner ear, MIRATAZ provides a safe and effective alternative to oral medication for cats that are resistant to pills or experiencing nausea. Mirtazapine works by modulating serotonin and norepinephrine levels in the brain—neurotransmitters involved in mood, appetite, and the nausea reflex—making it particularly helpful for feline patients suffering from appetite suppression due to illness or chemotherapy. As both an antiemetic and appetite stimulant, it is often used in veterinary oncology care plans to support nutritional intake and improve quality of life. MIRATAZ is generally well tolerated, though side effects such as restlessness, vocalization, increased activity, or mild nausea may occur. Rare reactions include swelling or vomiting. Caution is advised in cats with liver conditions or those taking medications that affect serotonin levels. Owners should monitor for signs of serotonin syndrome or behavioral changes during treatment. Keep the application site dry and avoid water exposure. Store the ointment at room temperature and out of reach of children and other animals. Follow your veterinarian’s instructions closely for dosage and application to ensure safety and effectiveness in managing feline appetite and nausea.